Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Emory University
Centre Francois Baclesse
University of Wisconsin, Madison
Eastern Cooperative Oncology Group
University of Pisa
University of Colorado, Denver
AstraZeneca
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
National Taiwan University Hospital
Emory University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
NRG Oncology
University of Nebraska
VLP Therapeutics
NRG Oncology
National Taiwan University Hospital
Virginia Commonwealth University
Medical University of South Carolina
New York University
Inhibrx Biosciences, Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Rigshospitalet, Denmark
University of Colorado, Denver
Centre hospitalier de l'Université de Montréal (CHUM)
National Taiwan University Hospital
Travera Inc
Institut Claudius Regaud
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
University of British Columbia
Mayo Clinic
University of British Columbia
Zhongnan Hospital
University of Palermo
Medical College of Wisconsin
University of Michigan
Columbia University